LMMY · Exousia Bio, Inc.
$0.02
+0.00 (+26.67%)
At close · Sep 2
Going-concern doubt
— flagged Jun 16, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company has not yet established an ongoing source of revenue sufficient to cover its operating costs and allow it to continue as a going concern. The Company has accumulated deficit from inception (January 31, 2022) to February 28, 2026, of $288,623. These factors among others raise substantial doubt about the ability of the company to continue as a going concern for a reasonable period of time.”View the 10-Q filed Jun 16, 2026
Market Cap
$944,999
Shares
52.50M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-06-16 | 2026-02-28 | |
| 10-Q | 2026-03-17 | 2025-11-30 | |
| 8-K | 2025-11-17 | 2025-11-11 | |
| 10-Q | 2025-11-17 | 2025-08-31 | |
| 10-K | 2025-10-17 | 2025-05-31 | |
| 10-Q | 2025-04-24 | 2025-02-28 | |
| 10-Q | 2025-01-10 | 2024-11-30 | |
| 8-K | 2024-12-17 | 2024-12-06 | |
| 10-Q | 2024-10-11 | 2024-08-31 | |
| 10-K | 2024-08-30 | 2024-05-31 | |
| 8-K | 2024-08-29 | 2024-07-23 | |
| 10-Q | 2024-04-15 | 2024-02-29 | |
| 10-Q | 2024-01-16 | 2023-11-30 | |
| 10-K/A | 2023-11-16 | 2023-05-31 | |
| 10-Q | 2023-10-11 | 2023-08-31 | |
| 10-K | 2023-09-01 | 2023-05-31 | |
| 10-Q | 2023-05-08 | 2023-02-28 | |
| 8-K | 2023-03-17 | 2023-03-15 |
Showing 1–18 of 18 filings